WHO prequalifies artemether-lumefantrine for babies weighing two to five kilograms Last updated: April 25, 2026 | 13:36 The newly prequalified treatment, artemether-lumefantrine, is the first antimalarial formulation designed specifically for the youngest malaria patients REUTERS Dubai: The World Health Organisation (WHO) has reached a milestone in the global fight against malaria, announcing the prequalification of the first treatment specifically designed for newborns and young infants. The medicine, a specially developed formulation of artemether-lumefantrine, has been intended for babies weighing between two and five kilograms and the first antimalarial treatment created specifically for this highly vulnerable age group.…